Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabineMaik Tretbar, Finn K. Hansen|ChemRxiv|2024Cited by 1
Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabineMaik Tretbar, Finn K. Hansen|ChemRxiv|2024Cited by 1